About us

KDN Biotech functions as the outward-facing international sales and marketing arm for product lines developed and manufactured by its parent company, Vland Biotech, a leading force in biotech innovation listed on the Shanghai Stock Exchange.

KDN’s business scope spans industrial enzymes catering to several specialized industries with enzymes that optimize routine processes across textile, detergent, and pulp and paper industries. KDN’s second specialty includes an expansive line of probiotics designed for animal, plant, and human consumption.

KDN’s leading edge in these core areas stem from Vland’s research and development activities, which apart from enzymes and probiotics include vaccines and animal health. Lending expertise to these verticals are Vland’s 23 affiliate companies, 8 technical centers, 2 innovation laboratories, and 9 manufacturing facilities.

The group employs 26 Ph.Ds and nearly 300 associates with Master’s degrees. Vland has been granted 232 patents by the China National Intellectual Property Administration, as well as a dozens of patents from American, European and other international intellectual property authorities.